Sagimet Biosciences Virtual KOL Event - A Novel Mechanism of Action for Treating Acne: Update on the Planned Phase 3 Trial of Denifanstat for the Treatment of Moderate to Severe Acne for the US 04/30/2026 at 2:00 PM EDT Listen to webcast Supporting Materials View Presentation 730.9 KB
